The Age-Specific Quantitative Effects of Metabolic Risk Factors on Cardiovascular Diseases and Diabetes: A Pooled Analysis
Open accessThe DOI matches its Crossref record; 66 of the 67 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The effects of systolic blood pressure (SBP), serum total cholesterol (TC), fasting plasma glucose (FPG), and body mass index (BMI) on the risk of cardiovascular diseases (CVD) have been established in epidemiological studies, but consistent estimates of effect sizes by age and sex are not available. METHODS: We reviewed large cohort pooling projects, evaluating effects of baseline or usual exposure to metabolic risks on ischemic heart disease (IHD), hypertensive heart disease (HHD), stroke, diabetes, and, as relevant selected other CVDs, after adjusting for important confounders. We pooled all data to estimate relative risks (RRs) for each risk factor and examined effect modification by age or other factors, using random effects models. RESULTS: Across all risk factors, an average of 123 cohorts provided data on 1.4 million individuals and 52,000 CVD events. Each metabolic risk factor was robustly related to CVD. At the baseline age of 55-64 years, the RR for 10 mmHg higher SBP was largest for HHD (2.16; 95% CI 2.09-2.24), followed by effects on both stroke subtypes (1.66; 1.39-1.98 for hemorrhagic stroke and 1.63; 1.57-1.69 for ischemic stroke). In the same age group, RRs for 1 mmol/L higher TC were 1.44 (1.29-1.61) for IHD and 1.20 (1.15-1.25) for ischemic stroke. The RRs for 5 kg/m(2) higher BMI for ages 55-64 ranged from 2.32 (2.04-2.63) for diabetes, to 1.44 (1.40-1.48) for IHD. For 1 mmol/L higher FPG, RRs in this age group were 1.18 (1.08-1.29) for IHD and 1.14 (1.01-1.29) for total stroke. For all risk factors, proportional effects declined with age, were generally consistent by sex, and differed by region in only a few age groups for certain risk factor-disease pairs. CONCLUSION: Our results provide robust, comparable and precise estimates of the effects of major metabolic risk factors on CVD and diabetes by age group.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and the risk of CVD increases continuously with rising fasting plasma glucose levels, even before reaching levels sufficient for a diabetes diagnosis [5].”
From Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017 (2018) · cites this paper as [5]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Self-citation(2002) · The Lancet · doi:10.1016/s0140-6736(02)11911-8 · Cited by 10,266
Self-citationTurner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397 · cited 1×
“For BMI and FPG, confounding remains a concern as evidence from randomized trials of disease outcomes is either very limited for practical reasons (BMI) or provides mixed results (FPG) [49–52].”
BackgroundBariatric Surgery: A Systematic Review and Meta-analysis
Buchwald, H., Avidor, Y., Braunwald, E., Jensen, M. D., Pories, W., Fahrbach, K., & Schoelles, K. (2004) · JAMA · doi:10.1001/jama.292.14.1724 · Cited by 6,800 · cited 14×
“Metabolic risk factors We compared and pooled RRs for the effects of key metabolic risk factors: SBP, TC, FPG, and adiposity measured by BMI, from major global pooling projects.”
BackgroundInfluentialCholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550
The Emerging Risk Factors Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)60484-9 · Cited by 5,125
Research works printed but not linked: 2
- James WPT, Jackson-Leach R, Ni Mhurchu C, Kalamara E, Shayeghi M, <etal>et al</etal>.. (2004) Overweight and obesity (high body mass index). In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, editors. Comparative quantification of health risks. Geneva: World Health Organization. pp. 497–596.
- Lawes CM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, <etal>et al</etal>.. (2004) High Blood Pressure. In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, editors. Comparative quantification of health risks. Geneva: World Health Organization. pp. 497–596.
Cited by
Items 101–200 of 772
Gender Differences in Obesity-Related Cancers
Argyrakopoulou, G., Dalamaga, Μ., Spyrou, N., & Kokkinos, A. D. (2021) · Current Obesity Reports · doi:10.1007/s13679-021-00426-0 · Cited by 94
Li, Y., He, Y., Yang, L., Liu, Q., Li, C., Wang, Y., Yang, P., Wang, J., Chen, Z., & Huang, X. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.801582 · Cited by 84
Time trends and projected obesity epidemic in Brazilian adults between 2006 and 2030
Estivaleti, J. M., Guzman-Habinger, J. M., Lobos, J., Azeredo, C. M., Claro, R. M., Ferrari, G., Adami, F., & Rezende, L. F. M. (2022) · Scientific Reports · doi:10.1038/s41598-022-16934-5 · Cited by 94
Adair, T., & López, A. D. (2020) · BMC Medicine · doi:10.1186/s12916-020-01666-y · Cited by 88
Diederichsen, A. C. P., Rasmussen, L. M., Søgaard, R., Lambrechtsen, J., Steffensen, F. H., Frost, L., Egstrup, K., Urbonavičienė, G., Busk, M., Olsen, M. H., et al. (2015) · Trials · doi:10.1186/s13063-015-1082-6 · Cited by 86
“However, in individuals older than 65 years, the risk scores should be interpreted more leniently due to a lack of evidence [8, 9].”
BackgroundPearson-Stuttard, J., Cheng, Y. J., Bennett, J., Vamos, E. P., Zhou, B., Valabhji, J., Cross, A. J., Ezzati, M., & Gregg, E. W. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00288-6 · Cited by 76
Self-citationConsumption of processed red meat and its impact on human health: A review
Libera, J., Iłowiecka, K., & Stasiak, D. M. (2021) · International Journal of Food Science & Technology · doi:10.1111/ijfs.15270 · Cited by 95
Collaborators, G. 2. E. M. R. O. (2017) · International Journal of Public Health · doi:10.1007/s00038-017-1002-5 · Cited by 94
“While these observational studies are not specifically from the EMR, the attributable effect of BMI on the three diseases has been shown to remain the same across different regions from the world (Singh et al. 2013).”
Tarín‐Carrasco, P., İm, U., Geels, C., Palacios-Peña, L., & Jiménez‐Guerrero, P. (2021) · Environment International · doi:10.1016/j.envint.2021.106517 · Cited by 80
The association between frailty, the metabolic syndrome, and mortality over the lifespan
Kane, A. E., Gregson, E., Theou, O., Rockwood, K. J., & Howlett, S. E. (2017) · GeroScience · doi:10.1007/s11357-017-9967-9 · Cited by 82
“On the other hand, several studies have shown no association of the metabolic syndromewith either CVD (Sattar et al. 2008; Singh et al. 2013) or mortality risk (Hao et al.”
InfluentialObesity is associated with reduced cerebral blood flow – modified by physical activity
Knight, S. P., Laird, E. J., Williamson, W., O’Connor, J. D., Newman, L., Carey, D., Looze, C. D., Fagan, A. J., Chappell, M. A., Meaney, J. F., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.04.008 · Cited by 81
Scharf, D. M., Eberhart, N. K., Hackbarth, N. S., Horvitz-Lennon, M. V., Beckman, R., Han, B., Lovejoy, S. L., Pincus, H. A., & Burnam, M. A. (2014) · Rand health quarterly · doi:10.7249/rhq-04-03-06 · Cited by 74
“In any case, observed changes in FPG and A1c for the general and “at risk” samples were unlikely to be associated with any reduced risk for diabetes-related complications such as ischemic heart disease and stroke (Singh et al., 2013).”
Lipid-lowering in diabetes: An update
Chait, A., Eckel, R. H., Vrablík, M., & Zambon, A. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.117313 · Cited by 81
Zhang, H., Wu, Q., Xiao, W. L., & Qin, X. (2020) · Food Bioscience · doi:10.1016/j.fbio.2020.100682 · Cited by 70
Gill, D., Zuber, V., Dawson, J., Pearson-Stuttard, J., Carter, A. R., Sanderson, E., Karhunen, V., Levin, M. G., Wootton, R. E., Klarin, D., et al. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-00807-4 · Cited by 67
Preeclampsia and Obesity—The Preventive Role of Exercise
Poniedziałek‐Czajkowska, E., Mierzyński, R., & Leszczyńska‐Gorzelak, B. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20021267 · Cited by 94
Wang, L., Lauren, B. N., Hager, K., Zhang, F. F., Wong, J. B., Kim, D. D., & Mozaffarian, D. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.029215 · Cited by 72
“2,23,24 Because these observed effects assess how dietary differences relate to clinical risk in populations, they inherently incorporate the overall impact including the average dietary complements and substitutes in the population.”
Self-citationLee, Y., Mozaffarian, D., Sy, S., Liu, J., Wilde, P., Marklund, M., Abrahams‐Gessel, S., Gaziano, T. A., & Micha, R. (2020) · Circulation · doi:10.1161/circulationaha.119.042956 · Cited by 84
Self-citationThe potential of DNA methylation as a biomarker for obesity and smoking
Heikkinen, A., Bollepalli, S., & Ollikainen, M. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13496 · Cited by 77
Liang, R., Feng, X., Shi, D., Yang, M., Yu, L., Liu, W., Zhou, M., Wang, X., Qiu, W., Fan, L., et al. (2022) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3572 · Cited by 78
“It was computed by taking the person‐year weighted average of the FPG level associated with the lowest risk of mortality in the pooled analyses of prospective cohort studies.(13) Deaths and DALYs were used to assess the attributable burden of HFPG.”
MethodOtto, M. C. D. O., Afshin, A., Micha, R., Khatibzadeh, S., Fahimi, S., Singh, G. M., Danaei, G., Sichieri, R., Monteiro, C. A., Louzada, M. L. D. C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151503 · Cited by 87
“RRs for both sexes combined was used for men and women, since results from meta-analyses indicated no material differences in RRs by sex [29].”
BackgroundMethodInfluentialSelf-citationAssociation Between BMI and Obesity With Survival in Pulmonary Arterial Hypertension
Weatherald, J. C., Huertas, A., Boucly, A., Guignabert, C., Taniguchi, Y., Adir, Y., Jevnikar, M., Savale, L., Jaïs, X., Peng, M., et al. (2018) · CHEST Journal · doi:10.1016/j.chest.2018.05.006 · Cited by 71
A Contemporary Review of the Relationship between Red Meat Consumption and Cardiovascular Risk
Bronzato, S., & Durante, A. (2017) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_206_16 · Cited by 72
“[68] Moreover, to its action on blood pressure and thus its indirect role in the increased cardiovascular events, sodium intake has been demonstrated to independently increase the risk of CVD.[69] The sodium contained in a daily 50 g serving of processed meat would predict most of the observed 42% higher risk seen in…”
BackgroundInfluentialCost‐utility analysis of the National Health Screening Program for chronic kidney disease in Korea
Go, D., Kim, S., Park, J., Ryu, D., Lee, H., & Jo, M. (2017) · Nephrology · doi:10.1111/nep.13203 · Cited by 67
“For incidence rate of complication in high risk groups, we multiplied the relative risks on incidence of MI and stroke in diabetic and hypertensive patients compared to the normal population from the previous studies.(16,17,20) Each CKD multiplier for CVD risks is in Table 1.”
ResultAlbrektsen, G., Heuch, I., Løchen, M., Thelle, D. S., Wilsgaard, T., Njølstad, I., & Bønaa, K. H. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.04.009 · Cited by 73
Pearson‐Stuttard, J., Kypridemos, C., Collins, B., Mozaffarian, D., Huang, Y., Bandosz, P., Capewell, S., Whitsel, L. P., Wilde, P., O’Flaherty, M., et al. (2018) · PLoS Medicine · doi:10.1371/journal.pmed.1002551 · Cited by 78
Self-citationAbar, L., Sobiecki, J. G., Cariolou, M., Nanu, N., Vieira, A., Stevens, C. A. T., Aune, D., Greenwood, D. C., Chan, D. S. M., & Norat, T. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz045 · Cited by 66
“Excess weight and obesity have been linked to several chronic diseases including cardiovascular disease [2,3], diabetes [3] and many types of cancersincluding lympho-hematopoietic cancers [4] .”
BackgroundGutierrez, J., Alloubani, A., Mari, M., & Alzaatreh, M. (2018) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401812010041 · Cited by 68
“This is probably because as individuals age, they tend to participate less in physical activities which are essential to reduce sugar levels [26].”
BackgroundKozuharova, E. K., Matkowski, A., Woźniak, D., Simeonova, R., Naychov, Z., Malainer, C., Mocan, A., Nabavi, S. M., & Atanasov, A. G. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00333 · Cited by 63
“The risk of cardiovascular disease development elevates with rising fasting plasma glucose levels, even at lower values than those that meet the criteria for a diabetes diagnosis (Danaei et al., 2006; Singh et al., 2013).”
BackgroundNascimento, B. R., Brant, L. C. C., Yadgir, S., de Oliveira, G. M. M., Roth, G. A., Glenn, S., Mooney, M., Naghavi, M., Passos, V. M. D. A., Duncan, B. B., et al. (2020) · Population Health Metrics · doi:10.1186/s12963-020-00218-z · Cited by 65
He, S., Wang, J., Zhang, J., & Xu, J. (2021) · Obesity · doi:10.1002/oby.23023 · Cited by 60
“Weight gain is associated with an increased risk of chronic diseases, such as diabetes mellitus (2), cardiovascular disease (2), chronic kidney disease (3), metabolic syndrome (4), cancer (5), and musculoskeletal disorders (6), which not only have negative physical effects but also increase the financial burden on soc…”
BackgroundNilson, E. A. F., Metlzer, A. B., Labonté, M., & Jaime, P. C. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235514 · Cited by 69
“The attributable costs estimates may also be underestimated because of differences between the studies on relative risks used by PRIME and larger and more recent meta-analyses [41] [42], which consider more age-specific differences, especially regarding adolescents and young adults.”
ResultKim, H., Lee, C. J., Ahn, S. H., Lee, K. S., Lee, B. K., Baik, S. J., Kim, S. U., & Lee, J. I. (2022) · Digestive Diseases and Sciences · doi:10.1007/s10620-022-07508-6 · Cited by 62
Population differentiation in allele frequencies of obesity-associated SNPs
Mao, L., Fang, Y., Campbell, M. C., & Southerland, W. M. (2017) · BMC Genomics · doi:10.1186/s12864-017-4262-9 · Cited by 68
Alves-Silva, J. M., Zuzarte, M., Girão, H., & Salgueiro, L. (2021) · Molecules · doi:10.3390/molecules26123506 · Cited by 63
Russa, D. L., Giordano, F., Marrone, A., Parafati, M., Janda, E., & Pellegrino, D. (2019) · Antioxidants · doi:10.3390/antiox8030066 · Cited by 62
“Epidemiologic studies have highlighted the strong correlation between high body mass index (BMI) and several chronic diseases, including cardiovascular disease [3,4], cancers [5], and renal diseases [6–8].”
BackgroundObesity, inflammation, and cancer in dogs: Review and perspectives
Marchi, P. H., Vendramini, T. H. A., Perini, M. P., Zafalon, R. V. A., Amaral, A. R., Ochamotto, V. A., da Silveira, J. C., Dagli, M. L., & Brunetto, M. A. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.1004122 · Cited by 80
“Moreover, obesity predisposes patients to other diseases, such as diabetes mellitus, cardiovascular diseases, hypertension (11), orthopedic disorders (12), sleep apnea (10) and certain types of neoplasias (13).”
BackgroundFontvieille, E., Viallon, V., Recalde, M., Córdova, R., Jansana, A., Peruchet‐Noray, L., Lennon, H., Heath, A. K., Aune, D., Christakoudi, S., et al. (2023) · BMC Medicine · doi:10.1186/s12916-023-03114-z · Cited by 65
“Over-weight and obesity increase the risk of non-communicable diseases (NCDs) including cardiometabolic diseases (CMD) [2]—such as type 2 diabetes (T2D) and cardio-vascular diseases (CVD)—and cancer [3].”
BackgroundIntermittent fasting versus continuous calorie restriction: which is better for weight loss?
Zhang, Q., Zhang, C., Wang, H., Ma, Z., Liu, D., Guan, X., Liu, Y., Fu, Y., Cui, M., & Dong, J. (2022) · Nutrients · doi:10.3390/nu14091781 · Cited by 53
“Epidemiological studies showed that elevated BMI could cause cardiovascular disease, diabetes mellitus, chronic kidney disease [46,47], cancers [48], and musculoskeletal disorders [49,50].”
BackgroundRamsay, M., Crowther, N. J., Agongo, G., Ali, S. A., Asiki, G., Boua, P. R., Gómez-Olivé, F. X., Kahn, K., Khayeka‐Wandabwa, C., Mashinya, F., et al. (2018) · Global Health Action · doi:10.1080/16549716.2018.1556561 · Cited by 58
Ma, J., Li, C., Wang, J., & Gu, J. (2020) · Obesity · doi:10.1002/oby.22700 · Cited by 55
“It is a major contributor to a variety of chronic diseases, including type 2 diabetes, hypertension, cardiovascular disease, nonalcoholic fatty liver disease, stroke, and osteoarthritis (2-5), with enormous economic burden on both families and society (6,7).”
BackgroundSpringmann, M., Kennard, H., Dalin, C., & Freund, F. (2022) · Nature Food · doi:10.1038/s43016-023-00852-4 · Cited by 72
“…was primarily focused on mortality from chronic diseases, we focused on adults aged 20 years or older, and we adjusted the relative-risk estimates for attenuation with age based on a pooled analysis of cohort studies focused on metabolic risk factors 49 , in line with other assessments 23,50 .”
MethodPellegrino, D., Russa, D. L., & Marrone, A. (2019) · Antioxidants · doi:10.3390/antiox8120594 · Cited by 57
“Several studies have highlighted the solid correlation between obesity and chronic diseases, including cardiovascular disease [63,64], cancers [65–67], and renal diseases [68–70].”
BackgroundBurden of stroke attributable to selected lifestyle risk factors in rural South Africa
Maredza, M., Bertram, M., Gómez-Olivé, F. X., & Tollman, S. M. (2016) · BMC Public Health · doi:10.1186/s12889-016-2805-7 · Cited by 55
“This is the same data used by the global burden of disease study in 2010 [20].”
BackgroundMethodLartey, S. T., Magnussen, C. G., Si, L., Boateng, G. O., de Graaff, B., Biritwum, R. B., Minicuci, N., Kowal, P. R., Blizzard, L., & Palmer, A. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215045 · Cited by 56
Najafi, F., Soltani, S., Matin, B. K., Karyani, A. K., Rezaei, S., Soofi, M., Salimi, Y., Moradinazar, M., Hajizadeh, M., Barzegar, L., et al. (2020) · BMC Public Health · doi:10.1186/s12889-020-8322-8 · Cited by 60
Bragg, F., Li, L., Bennett, D., Yu, C., Lewington, S., Bian, Z., Yang, L., Chen, J., Chen, Y., Collins, R., et al. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.1702 · Cited by 82
Self-citationLi, X., Jan, S., Yan, L. L., Hayes, A., Chu, Y.-B., Wang, H., Feng, X., Niu, W., He, F. J., Ma, J., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183033 · Cited by 53
Huang, C., Li, C., Zhao, F., Zhu, J., Wang, S., & Sun, G. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19084491 · Cited by 54
“Childhood obesity has been associated with obesity and increased risks for chronic disease in adulthood [4,5], and these adverse effects may last the whole lifetime [6].”
BackgroundCao, X., Zhao, Z., Kang, Y., Tian, Y., Song, Y., Wang, L., Zhang, L., Wang, X., Chen, Z., Zheng, C., et al. (2022) · The Lancet Public Health · doi:10.1016/s2468-2667(22)00232-8 · Cited by 51
Circulating Galectin‐3 Is Associated With Cardiometabolic Disease in the Community
Nayor, M. G., Wang, N., Larson, M. G., Vasan, R. S., Levy, D. A., & Ho, J. E. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002347 · Cited by 48
Duncan, B. B., França, E. B., Passos, V. M. D. A., Cousin, E., Ishitani, L. H., Malta, D. C., Naghavi, M., Mooney, M., & Schmidt, M. I. (2017) · Revista Brasileira de Epidemiologia · doi:10.1590/1980-5497201700050008 · Cited by 114
Wilding, J. P. H., Zourikian, N., Minno, M. N. D. D., Khair, K., Marquardt, N., Benson, G. M., Ozelo, M. C., & Hermans, C. R. J. R. (2018) · Obesity Reviews · doi:10.1111/obr.12746 · Cited by 53
“However, the large epidemiological studies required to identify BMI as an independent risk factor for CVD in the general population (85,86) may pose a considerable challenge to reproduce in the comparatively limited global population of PWH.”
BackgroundGupta, N., Hallman, D., Dumuid, D., Vij, A., Rasmussen, C. L., Jørgensen, M. B., & Holtermann, A. (2019) · International Journal of Obesity · doi:10.1038/s41366-019-0419-8 · Cited by 49
“05, otherwise a 1-less profile solution was retained; [2] Akaike Information Criterion (AIC) and the”
MethodThe Changing Nature of Mortality and Morbidity in Patients with Diabetes
Pearson-Stuttard, J., Buckley, J., Cicek, M., & Gregg, E. W. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2021.05.001 · Cited by 48
de Medeiros, G. C. B. S., Mesquita, G. X. B., Lima, S. C. V. C., Silva, D. F. O., de Azevedo, K. P. M., Pimenta, I. D. S. F., Gonçalves, A. K., Lyra, C. D. O., Martínez, D. G., & Piuvezam, G. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2058461 · Cited by 54
“…are still questions about the association of CVD with the consumption of other nutrients present in meat, such as saturated fatty acids (SFA) and heme iron (Bronzato and Durante, 2017; Chowdhury et al. 2014; Lacroix, Cantin, Nigam, 2017; Quintana et al., 2018; Singh et al. 2013; Zhang et al. 2012).”
BackgroundMazidimoradi, A., Momenimovahed, Z., Khalajinia, Z., Allahqoli, L., Salehiniya, H., & Alkatout, İ. (2024) · Health Science Reports · doi:10.1002/hsr2.1835 · Cited by 54
All-Cause and Cardiovascular Mortality Among Koreans
Sung, K., Ryu, S., Cheong, E. S., Kim, B. S., Kim, B. J., Kim, Y. B., Chung, P., Wild, S. H., & Byrne, C. D. (2015) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2015.02.010 · Cited by 49
Pretorius, E., Mbotwe, S., & Kell, D. B. (2017) · Scientific Reports · doi:10.1038/s41598-017-09860-4 · Cited by 50
Kohli-Lynch, C. N., Erzse, A., Rayner, B. L., & Hofman, K. J. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-055621 · Cited by 45
“37 For HHD, the HR decreased with older age and ranged from 1.63 to 2.86 per 10 mm Hg increase in SBP. 38 For the probabilistic analysis, we sampled hypertension rates from a Dirichlet distribution based on the NIDS 2017 analysis outlined above and IHD, stroke, CKD and HHD rates from Gamma…”
InfluentialHuo, C., Song, Z., Yin, J., Zhu, Y., Miao, X., Qian, H., Wang, J., Ye, L., & Zhou, L. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.917084 · Cited by 49
“Obesity affects nearly all physiological functions of the body and increases the risk of many diseases, such as diabetes mellitus, cardiovascular disease, musculoskeletal disorders and some cancers (including endometrial, breast, ovarian, kidney, and colon cancers) (Anandacoomarasamy et al., 2008; Singh et al., 2013;…”
BackgroundMortality attributable to sugar sweetened beverages consumption in Mexico: an update
Braverman‐Bronstein, A., Camacho‐García‐Formentí, D., Zepeda‐Tello, R., Cudhea, F., Singh, G. M., Mozaffarian, D., & Barrientos‐Gutiérrez, T. (2019) · International Journal of Obesity · doi:10.1038/s41366-019-0506-x · Cited by 54
“68]) were derived from pooled cohort analyses [21, 22].”
MethodSelf-citationSelf-compassion in weight management: A systematic review
Brenton-Peters, J., Consedine, N. S., Boggiss, A., Wallace-Boyd, K., Roy, R., & Serlachius, A. (2021) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2021.110617 · Cited by 44
Stanek, A., Brożyna-Tkaczyk, K., Zolghadri, S., Cholewka, A., & Myśliński, W. (2022) · Nutrients · doi:10.3390/nu14071509 · Cited by 51
Tan, M., He, F. J., Morris, J. K., & MacGregor, G. A. (2022) · BMJ Nutrition Prevention & Health · doi:10.1136/bmjnph-2021-000408 · Cited by 45
Dietary trends and obesity in Saudi Arabia
Alhusseini, N. K., AlSinan, N. A., Almutahhar, S., Khader, M., Tamimi, R., Elsarrag, M., Warar, R., Alnasser, S., Ramadan, M. M., Omair, A. A., et al. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1326418 · Cited by 49
Dumas, A.-A., & Desroches, S. (2019) · Current Obesity Reports · doi:10.1007/s13679-019-0324-4 · Cited by 37
Upstream Determinants of Overweight and Obesity in Europe
Vandevijvere, S., Pauw, R. D., Djojosoeparto, S. K., Gorasso, V., Guariguata, L., Løvhaug, A. L., Mialon, M., Dam, I. V., & von Philipsborn, P. (2023) · Current Obesity Reports · doi:10.1007/s13679-023-00524-1 · Cited by 55
Dienemann, T., Fujii, N., Li, Y., Govani, S., Kosaraju, N., Bloom, R. D., & Feldman, H. I. (2016) · Transplant International · doi:10.1111/tri.12807 · Cited by 42
“Although elevations in blood glucose lead to increases in cardiovascular risk outside of the setting of kidney disease [22,23], transient PTDM has not been linked to the same outcomes [24].”
BackgroundFive-Year Outcomes After Vertical Sleeve Gastrectomy for Severe Obesity: A Prospective Cohort Study
Flølo, T. N., Andersen, J. R., Kolotkin, R. L., Aasprang, A., Natvig, G. K., Hufthammer, K. O., & Våge, V. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2605-x · Cited by 44
Evaluation of the online Beverage Frequency Questionnaire (BFQ)
Vanderlee, L., Reid, J. L., White, C. M., Hobin, E. P., Acton, R. B., Jones, A. C., O’Neill, M., Kirkpatrick, S. I., & Hammond, D. G. (2018) · Nutrition Journal · doi:10.1186/s12937-018-0380-8 · Cited by 44
Hasan, M. M., Ahmed, S., Magalhães, R. J. S., Fatima, Y., Biswas, T., & Mamun, A. A. (2021) · European Journal of Clinical Nutrition · doi:10.1038/s41430-021-00945-y · Cited by 49
DeCleene, N. K., Kahn, E., Yuan, C.-W., Gakidou, E. E., Mokdad, A. H., Murray, C. J. L., Johnson, C. O., & Roth, G. A. (2026) · JAMA · doi:10.1001/jama.2025.26817 · Cited by 44
Self-reported health versus biomarkers: does unemployment lead to worse health?
Johansson, E., Böckerman, P., & Lundqvist, A. (2019) · Public Health · doi:10.1016/j.puhe.2019.10.005 · Cited by 45
“An elevated blood glucose level is an early indicator of diabetes and is also related to an elevated risk of cardiovascular diseases.(16) As this measure can be sensitive to the length of time spent fasting before measurement, individuals who had fasted for less than 4 h before measurement were excluded from that regr…”
BackgroundRestricting Branched-Chain Amino Acids within a High-Fat Diet Prevents Obesity
Liu, M., Huang, Y., Zhang, H., Aitken, D. A., Nevitt, M. C., Rockel, J. S., Pelletier, J., Lewis, C. E., Torner, J. C., Rampersaud, Y. R., et al. (2022) · Metabolites · doi:10.3390/metabo12040334 · Cited by 43
“Obesity is strongly associated with the development or aggravation of multiple comorbidities, such as diabetes mellitus [2], cardiovascular disease [2], osteoarthritis (OA) [3], and others [4–6].”
BackgroundInsights by which TUDCA is a potential therapy against adiposity
Freitas, I. N., junior, J. A. D. S., de Oliveira, K. M., Alves, B. L., Araújo, T. R., Camporez, J. P., Carneiro, E. M., & Davel, A. P. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1090039 · Cited by 45
“Obesity is a risk factor for developing many disorders such as diabetes mellitus, hypertension, cardiovascular events, obstructive sleep apnea syndrome, cancer, and musculoskeletal diseases (5).”
BackgroundSuppakitjanusant, P., Ji, Y., Stevenson, M. O., Chantrapanichkul, P., Sineath, R. C., Goodman, M. G., Alvarez, J. A., & Tangpricha, V. (2020) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2020.100230 · Cited by 48
“Several studies have documented that a high BMI is significantly associated, in both men and women, with metabolic syndrome [20,21], CVDVD [22–25] and mortality [26–29].”
BackgroundTrieu, K., Coyle, D. H., Afshin, A., Neal, B. C., Marklund, M., & Wu, J. H. Y. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003806 · Cited by 47
“where lnRRoa(y) is the increase in the natural logarithm of the relative risk of outcome (o) in age (a) per 10 mm Hg systolic blood pressure (SBP) increase (Table E in S1 File), derived from previous meta-analyses [20,21].”
BackgroundMethodResultInfluentialImpact of Dysfunctional Adipose Tissue Depots on the Cardiovascular System
D’Oria, R., Genchi, V. A., Caccioppoli, C., CALDERONI, I., Marrano, N., Biondi, G., Borrelli, A., Gioia, L. D., Giorgino, F., & Laviola, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214296 · Cited by 43
“Obesity increases the risk for developing multiple pathological conditions, including diabetes mellitus [2], cardiovascular disease (CVD) [2,3], multiple types of cancers [4], and musculoskeletal and mental disorders [5,6].”
BackgroundMcNarry, M. A., Wilson, R. P., Holton, M. D., Griffiths, I. W., & Mackintosh, K. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182333 · Cited by 41
Xu, H., Kuja‐Halkola, R., Chen, X., Magnusson, P. K. E., Svensson, P., & Carrero, J. J. (2019) · Kidney International · doi:10.1016/j.kint.2018.12.019 · Cited by 41
Inhibitory Antibodies against PCSK9 Reduce Surface CD36 and Mitigate Diet-Induced Renal Lipotoxicity
Byun, J. H., Lebeau, P. F., Platko, K., Carlisle, R. E., Faiyaz, M., Chen, J., MacDonald, M. E., Makda, Y., Yousof, T., Lynn, E. G., et al. (2022) · Kidney360 · doi:10.34067/kid.0007022021 · Cited by 36
Proteomic alterations underlie an association with teratozoospermia in obese mice sperm
Peng, Y., Zhao, W., Qu, F., Jing, J., Hu, Y., Liu, Y., & Ding, Z. (2019) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-019-0530-7 · Cited by 37
Bennett, J. P., Prado, C. M. M., Heymsfield, S. B., & Shepherd, J. (2024) · Obesity Reviews · doi:10.1111/obr.13767 · Cited by 42
Gad, M., Lord, J., Chalkidou, K., Asare, B. A., Gyansa‐Lutterodt, M., & Ruiz, F. J. (2019) · Value in Health · doi:10.1016/j.jval.2019.09.2749 · Cited by 42
Ion Channels in Obesity: Pathophysiology and Potential Therapeutic Targets
Vasconcelos, L. H. C., de Souza, I. L. L., Pinheiro, L. S., & da Silva, B. A. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00058 · Cited by 41
“…to weight gain and the development of chronic disorders, including arterial hypertension, type 2 diabetes mellitus, dyslipidemias, sleep apnea, and cancer (Jeffreys et al., 2003; Van Gaal et al., 2006; Pischon et al., 2008; Whitlock et al., 2009; Vucenik and Stains, 2012; Singh et al., 2013).”
BackgroundAdeyemi, W. J., Olayaki, L. A., Abdussalam, T. A., Toriola, A. P., Olowu, A. B., Yakub, A. J., & Raji, A. O. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110110 · Cited by 40
Li, Z., Liu, M., Wu, Z., Liu, Y., Li, W., Liu, M., Lv, S., Yu, S., Jiang, Y., Gao, B., et al. (2022) · Environment International · doi:10.1016/j.envint.2022.107301 · Cited by 37
Ormazábal, V., Nair, S., Carrión, F., McIntyre, D. H., & Salomón, C. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01597-3 · Cited by 45
“Adults with diabetes have a higher risk of developing CVD than those without diabetes, and the risk of CVD increases with fasting glucose concentrations, even before reaching diagnostic threshold concentrations [38].”
BackgroundSadeghian, M., Hosseini, S. A., Zare Javid, A., Ahmadi Angali, K., & Mashkournia, A. (2021) · Obesity Surgery · doi:10.1007/s11695-020-05202-y · Cited by 35
Emmert-Fees, K. M. F., Amies‐Cull, B., Wawro, N., Linseisen, J., Staudigel, M., Peters, A., Cobiac, L. J., O’Flaherty, M., Scarborough, P., Kypridemos, C., et al. (2023) · PLoS Medicine · doi:10.1371/journal.pmed.1004311 · Cited by 46
Lei, L., Li, J., Wang, W., Yu, Y., Pu, B., Peng, Y., Zhang, L., & Zhao, Z. (2024) · Obesity · doi:10.1002/oby.23986 · Cited by 39
“It has been identified as a risk factor for a set of chronic diseases, cancers, and osteoarthritis [3 – 5].”
BackgroundSuemoto, C. K., Lebrão, M. L., Duarte, Y. A. O., & Danaei, G. (2014) · The Journals of Gerontology Series A · doi:10.1093/gerona/glu165 · Cited by 48
“Several pooled analyses of prospective studies have reported larger relative risks for BMI in younger ages (31,32).”
BackgroundSelf-citationYakoob, M. Y., Micha, R., Khatibzadeh, S., Singh, G. M., Shi, P., Ahsan, H., Balakrishna, N., Brahmam, G. N. V., Chen, Y., Afshin, A., et al. (2016) · American Journal of Public Health · doi:10.2105/ajph.2016.303368 · Cited by 36
Self-citationRai, A., Gurung, S., Thapa, S., & Saville, N. M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216644 · Cited by 43
Bae, J. H., Choi, H. J., Cho, K. I. K., Kim, L. K., Kwon, J. S., & Cho, Y. M. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0018 · Cited by 33
Cai, S., Zhu, T., Ding, Y., Cheng, B., Zhang, A., Bao, Q., Sun, J., Li, M., Liu, X., & Wang, S. (2022) · Hypertension Research · doi:10.1038/s41440-022-01075-z · Cited by 33
Mick, P. T., Kabir, R., Pichora-Fuller, M. K., Jones, C., Moxham, L. M. R., Phillips, N. A., Urry, E., & Wittich, W. (2023) · Ear and Hearing · doi:10.1097/aud.0000000000001370 · Cited by 41
The Role of TLRs in Obesity and Its Related Metabolic Disorders
Campos-Bayardo, T. I., Román-Rojas, D., García-Sánchez, A., Cardona-Muñóz, E. G., Sánchez-Lozano, D. I., Totsuka-Sutto, S. E., Gómez-Hermosillo, L. F., Casillas-Moreno, J., Sierra, J. A., Pazarín–Villaseñor, L., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052229 · Cited by 37
“For these reasons, obesity is considered a state of low-grade chronic inflammation that favors an imbalance of different metabolic processes and the appearance of diseases that alter the quality of life and increase healthcare costs [24,25].”
Xie, F., Xiong, F., Yang, B., Yan, Z., Shen, Y., Qin, H., Chen, L., Chen, T., Chen, J., Zhu, S., et al. (2025) · BMC Public Health · doi:10.1186/s12889-025-23237-7 · Cited by 41
“Numerous studies have investigated the link between obesity and specific diseases [6, 7].”
Metadata
- Authors
- Singh, G. M., Danaei, G., Farzadfar, F., Stevens, G. A., Woodward, M., Wormser, D., Kaptoge, S., Whitlock, G., Qiao, Q., Lewington, S., Di Angelantonio, E., vander Hoorn, S., Lawes, C. M. M., Ali, M. K., Mozaffarian, D., Ezzati, M., Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group; Asia-Pacific Cohort Studies Collaboration (APCSC), (DECODE), D. E. C. A. O. D. C. I. E., Emerging Risk Factor Collaboration (ERFC), & Prospective Studies Collaboration (PSC)
- Affiliations
- Harvard University (US)
- Tehran University of Medical Sciences (IR)
- World Health Organization (CH)
- The University of Sydney (AU)
- University of Cambridge (GB)
- University of Oxford (GB)
- University of Helsinki (FI)
- University of Auckland (NZ)
- Emory University (US)
- Brigham and Women's Hospital (US)
- MRC Centre for Environment and Health (GB)
- Corresponding author
- Ezzati, Majid
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-07-30
- Volume
- 8
- Issue
- 7
- Pages
- e65174
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3728292
- OpenAlex
- W2122520859
- Cited by
- 772
- References
- 67
- Citations by year
- 2026: 29 · 2025: 64 · 2024: 84 · 2023: 87 · 2022: 103 · 2021: 86 · 2020: 85 · 2019: 66 · 2018: 43 · 2017: 49 · 2016: 41 · 2015: 18 · 2014: 16 · 2013: 1
- FWCI
- 19.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, cc-by)
- Pure Amsterdam UMC (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion)
- Monash University Research Portal (Monash University) (acceptedVersion, other-oa)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Työväentutkimus Vuosikirja (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Site cant be reached (submittedVersion, cc-by)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
- OPUS (Augsburg University) (submittedVersion, cc-by)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- World Health Organization
- National Institute for Health and Care Research (NF-SI-0512-10165)
- British Heart Foundation (RG/08/013/25942, RG/07/008/23674, RG/08/014/24067)
- Imperial College London
- Imperial College Healthcare NHS Trust
- Medical Research Council (MR/K005901/1, MR/L003120/1)
- Economic and Social Research Council (ES/F02679X/1)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK007703., T32DK007703)
- National Institute of Environmental Health Sciences (P30ES005605)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- metabolic risk factors, cardiovascular disease, diabetes mellitus, systolic blood pressure, total cholesterol, fasting blood glucose, body mass index, ischemic heart disease, hypertensive heart disease, stroke, sex differences, pooled cohort analysis, relative risk, effect modification by age
- MeSH terms
- Adult, Age Factors, Aged, Aged, 80 and over, Blood Glucose, Blood Pressure, Cardiovascular Diseases, Cholesterol, Diabetes Mellitus, Female, Humans, Male, Middle Aged, Risk, Sex Factors, Body Mass Index, Patient Outcome Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.